Crossmark

The CAPP II trial of aspirin in Lynch syndrome/HNPCC: is it time for everyone to be treated?

Crossref DOI link: https://doi.org/10.1007/s10689-020-00215-z

Published Online: 2021-01-09

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lynch, Patrick M. https://orcid.org/0000-0003-0125-3109
License Information

Text and Data Mining valid from 2021-01-01

Version of Record valid from 2021-01-01
More Information

Article History

Received: 17 September 2020

Accepted: 22 October 2020

First Online: 9 January 2021

Free to read: This content has been made available to all.